Yes. A work colleague (bio statistician with a PhD) explained that the margin of 'difference' when demonstrating similarity can considerably high which reduces the sample size........I explained the nature of the study which he (off the top of his head - so not formally calculated) suggested a similar number to you and............ hopefully we will achieve commercialisation sooner than many of us anticipated and see the end of the CR's. The release of the details of the study protocol would reduce a lot of angst amongst us holders.
- Forums
- ASX - By Stock
- AVR
- Clinical trials
Clinical trials, page-23
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.43 |
Change
-0.120(1.04%) |
Mkt cap ! $241.6M |
Open | High | Low | Value | Volume |
$11.58 | $11.58 | $11.17 | $196.0K | 17.23K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30 | $11.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.50 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30 | 11.400 |
1 | 500 | 11.300 |
2 | 1711 | 11.250 |
1 | 2000 | 11.150 |
1 | 471 | 11.140 |
Price($) | Vol. | No. |
---|---|---|
11.500 | 200 | 1 |
11.800 | 4634 | 1 |
11.830 | 500 | 1 |
11.850 | 164 | 1 |
11.900 | 1000 | 1 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online